Androgen Deprivation Therapy (ADT) Market Share, Application Analysis, Regional outlook, Growth, Trends, Key Players, Competitive Strategies and Forecast 2021 to 2030

In a recently published report, Androgen Deprivation Therapy (ADT) Market report for till 2030. The report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Androgen Deprivation Therapy (ADT) Market products.

Request To Download Sample of This Strategic Report:

Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018.

Global Spending on Health: A World in Transition”, released in theyear 2019 by the World Health Organization (WHO), the global spending on healthcare recorded USD 7.8 trillion in 2017, which was an increase by USD 0.2 trillion from the recorded value of USD 7.6 trillion in 2016.

Recently, a significant growth in healthcare spending have been observed in the low- and middle-income nations. In the middle-income nations, healthcare spending rose by 6.3% a year between 2000 and 2017, while the economy rose by 5.9% a year. Additionally, health spending in low-income countries also observed a growth by 7.8% a year in the same period. The growth in the healthcare spending of these nations can be attributed to the increasing focus of the governments in these nations to meet the laid down targets of the Sustainable Development Goals (SDGs) of 2030. Such factors are anticipated to drive the growth of the ANDROGEN DEPRIVATION THERAPY (ADT) MARKET during the forecast period.

Request To Download Sample of This Strategic Report:

Androgen deprivation therapy (ADT) is a type of antihormone therapy which is primarily utilized in the cure of prostate cancer. Prostate cancer cells typically requires androgen hormones such as testosterone to grow. The use of androgen deprivation therapy reduces the level of androgen hormones, with surgery or drug delivery to prevent the prostate cells from rising. Various studies have determined that ADT has shown the benefits in patients with metastatic disease, and as an addition to radiation therapy in patients with locally developed disease, including those with adverse intermediate-risk or extreme-risk localized disease. Surging incidences of prostate cancer, rising male geriatric population, along with increasing government efforts to implement & conduct programs for creating of awareness of screening tests such as Prostate-Specific Antigen (PSA) blood tests are the few factor responsible for high CAGR of the market over the forecast period. For instance, according to the GLOBOCAN 2018 estimates in 2018, about 1,276,106 new cases of prostate cancer were registered worldwide, representing 7.1% of all cancers in men. Similarly, As per the Canadian Cancer Society, it is estimated that 22,900 men will be diagnosed with prostate cancer in 2019 and this represents 20% of all new cancer cases in men in 2019. Moreover, technological advancement in screening & diagnostic tests is one of the major factor projected to create lucrative growth opportunities to the market growth in the forecasting years. However, side effects associated with ADT is the major factor restraining the growth of global Androgen Deprivation Therapy (ADT) market during the forecast period of 2019-2026.

The regional analysis of global Androgen Deprivation Therapy (ADT) Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging investments in R&D for the development of newer immunotherapies and targeted drug therapies to treat prostate cancer in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period due to rising awareness among patient towards the treatment of prostate cancer. Further, increasing number of government programs to promote the adoption of ADT, would also create a lucrative opportunity for the growth of the market in the Asia-Pacific region.

 Market player included in this report are::
Pfizer Inc.
Astellas Pharma Inc.
Johnson & Johnson
Novartis International AG
Veru Inc.
Sanofi S.A.
GlaxoSmithKline plc
Bayer AG
Orion Corporation
AstraZeneca Plc.

Read More:

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
LHRH Agonists
LHRH Antagonist

By Route of Administration:

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
Asia Pacific
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Androgen Deprivation Therapy (ADT) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Request To Download Sample of This Strategic Report:

About Kenneth Research:
Kenneth Research is a reselling agency which focuses on multi-client market research database. The primary goal of the agency is to help industry professionals including various individuals and organizations gain an extra edge of competitiveness and help them identify the market trends and scope. The quality reports provided by the agency aims to make decision making easier for industry professionals and take firm decisions which helps them to form strategies after complete assessment of the market. Some of the industries under focus include healthcare & pharmaceuticals, ICT & Telecom, automotive and transportation, energy and power, chemicals, FMCG, food and beverages, aerospace and defense and others. Kenneth Research also focuses on strategic business consultancy services and offers a single platform for the best industry market research reports.

Contact Us
Kenneth Research
Phone: +1 313 462 1072

E-Prescribing Market
Operating Room Integration Market
Veterinary Reference Laboratory Market
Population Health Management Market
Microscopy Market

Share your love
Christophe Rude

Christophe Rude

Articles: 15888

Leave a Reply

Your email address will not be published. Required fields are marked *